Rembrandt

Helping personalized medicine become a reality through integrative translational research

Subha Madhavan, Jean Claude Zenklusen, Yuri Kotliarov, Himanso Sahni, Howard A. Fine, Kenneth Buetow

Research output: Contribution to journalArticle

222 Citations (Scopus)

Abstract

Finding better therapies for the treatment of brain tumors is hampered by the lack of consistently obtained molecular data in a large sample set and the ability to integrate biomedical data from disparate sources enabling translation of therapies from bench to bedside. Hence, a critical factor in the advancement of biomedical research and clinical translation is the ease with which data can be integrated, redistributed, and analyzed both within and across functional domains. Novel biomedical informatics infrastructure and tools are essential for developing individualized patient treatment based on the specific genomic signatures in each patient's tumor. Here, we present Repository of Molecular Brain Neoplasia Data (Rembrandt), a cancer clinical genomics database and a Web-based data mining and analysis platform aimed at facilitating discovery by connecting the dots between clinical information and genomic characterization data. To date, Rembrandt contains data generated through the Glioma Molecular Diagnostic Initiative from 874 glioma specimens comprising ∼566 gene expression arrays, 834 copy number arrays, and 13,472 clinical phenotype data points. Data can be queried and visualized for a selected gene across all data platforms or for multiple genes in a selected platform. Additionally, gene sets can be limited to clinically important annotations including secreted, kinase, membrane, and known gene-anomaly pairs to facilitate the discovery of novel biomarkers and therapeutic targets. We believe that Rembrandt represents a prototype of how high-throughput genomic and clinical data can be integrated in a way that will allow expeditious and efficient translation of laboratory discoveries to the clinic.

Original languageEnglish (US)
Pages (from-to)157-167
Number of pages11
JournalMolecular Cancer Research
Volume7
Issue number2
DOIs
StatePublished - Feb 1 2009
Externally publishedYes

Fingerprint

Precision Medicine
Translational Medical Research
Brain
Neoplasms
Glioma
Genes
Therapeutics
Informatics
Data Mining
Molecular Pathology
Information Storage and Retrieval
Genomics
Brain Neoplasms
Biomedical Research
Phosphotransferases
Biomarkers
Databases
Phenotype
Gene Expression
Membranes

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Oncology

Cite this

Rembrandt : Helping personalized medicine become a reality through integrative translational research. / Madhavan, Subha; Zenklusen, Jean Claude; Kotliarov, Yuri; Sahni, Himanso; Fine, Howard A.; Buetow, Kenneth.

In: Molecular Cancer Research, Vol. 7, No. 2, 01.02.2009, p. 157-167.

Research output: Contribution to journalArticle

Madhavan, Subha ; Zenklusen, Jean Claude ; Kotliarov, Yuri ; Sahni, Himanso ; Fine, Howard A. ; Buetow, Kenneth. / Rembrandt : Helping personalized medicine become a reality through integrative translational research. In: Molecular Cancer Research. 2009 ; Vol. 7, No. 2. pp. 157-167.
@article{ce4af66a1b5746919f6a46744adc3af4,
title = "Rembrandt: Helping personalized medicine become a reality through integrative translational research",
abstract = "Finding better therapies for the treatment of brain tumors is hampered by the lack of consistently obtained molecular data in a large sample set and the ability to integrate biomedical data from disparate sources enabling translation of therapies from bench to bedside. Hence, a critical factor in the advancement of biomedical research and clinical translation is the ease with which data can be integrated, redistributed, and analyzed both within and across functional domains. Novel biomedical informatics infrastructure and tools are essential for developing individualized patient treatment based on the specific genomic signatures in each patient's tumor. Here, we present Repository of Molecular Brain Neoplasia Data (Rembrandt), a cancer clinical genomics database and a Web-based data mining and analysis platform aimed at facilitating discovery by connecting the dots between clinical information and genomic characterization data. To date, Rembrandt contains data generated through the Glioma Molecular Diagnostic Initiative from 874 glioma specimens comprising ∼566 gene expression arrays, 834 copy number arrays, and 13,472 clinical phenotype data points. Data can be queried and visualized for a selected gene across all data platforms or for multiple genes in a selected platform. Additionally, gene sets can be limited to clinically important annotations including secreted, kinase, membrane, and known gene-anomaly pairs to facilitate the discovery of novel biomarkers and therapeutic targets. We believe that Rembrandt represents a prototype of how high-throughput genomic and clinical data can be integrated in a way that will allow expeditious and efficient translation of laboratory discoveries to the clinic.",
author = "Subha Madhavan and Zenklusen, {Jean Claude} and Yuri Kotliarov and Himanso Sahni and Fine, {Howard A.} and Kenneth Buetow",
year = "2009",
month = "2",
day = "1",
doi = "10.1158/1541-7786.MCR-08-0435",
language = "English (US)",
volume = "7",
pages = "157--167",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Rembrandt

T2 - Helping personalized medicine become a reality through integrative translational research

AU - Madhavan, Subha

AU - Zenklusen, Jean Claude

AU - Kotliarov, Yuri

AU - Sahni, Himanso

AU - Fine, Howard A.

AU - Buetow, Kenneth

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Finding better therapies for the treatment of brain tumors is hampered by the lack of consistently obtained molecular data in a large sample set and the ability to integrate biomedical data from disparate sources enabling translation of therapies from bench to bedside. Hence, a critical factor in the advancement of biomedical research and clinical translation is the ease with which data can be integrated, redistributed, and analyzed both within and across functional domains. Novel biomedical informatics infrastructure and tools are essential for developing individualized patient treatment based on the specific genomic signatures in each patient's tumor. Here, we present Repository of Molecular Brain Neoplasia Data (Rembrandt), a cancer clinical genomics database and a Web-based data mining and analysis platform aimed at facilitating discovery by connecting the dots between clinical information and genomic characterization data. To date, Rembrandt contains data generated through the Glioma Molecular Diagnostic Initiative from 874 glioma specimens comprising ∼566 gene expression arrays, 834 copy number arrays, and 13,472 clinical phenotype data points. Data can be queried and visualized for a selected gene across all data platforms or for multiple genes in a selected platform. Additionally, gene sets can be limited to clinically important annotations including secreted, kinase, membrane, and known gene-anomaly pairs to facilitate the discovery of novel biomarkers and therapeutic targets. We believe that Rembrandt represents a prototype of how high-throughput genomic and clinical data can be integrated in a way that will allow expeditious and efficient translation of laboratory discoveries to the clinic.

AB - Finding better therapies for the treatment of brain tumors is hampered by the lack of consistently obtained molecular data in a large sample set and the ability to integrate biomedical data from disparate sources enabling translation of therapies from bench to bedside. Hence, a critical factor in the advancement of biomedical research and clinical translation is the ease with which data can be integrated, redistributed, and analyzed both within and across functional domains. Novel biomedical informatics infrastructure and tools are essential for developing individualized patient treatment based on the specific genomic signatures in each patient's tumor. Here, we present Repository of Molecular Brain Neoplasia Data (Rembrandt), a cancer clinical genomics database and a Web-based data mining and analysis platform aimed at facilitating discovery by connecting the dots between clinical information and genomic characterization data. To date, Rembrandt contains data generated through the Glioma Molecular Diagnostic Initiative from 874 glioma specimens comprising ∼566 gene expression arrays, 834 copy number arrays, and 13,472 clinical phenotype data points. Data can be queried and visualized for a selected gene across all data platforms or for multiple genes in a selected platform. Additionally, gene sets can be limited to clinically important annotations including secreted, kinase, membrane, and known gene-anomaly pairs to facilitate the discovery of novel biomarkers and therapeutic targets. We believe that Rembrandt represents a prototype of how high-throughput genomic and clinical data can be integrated in a way that will allow expeditious and efficient translation of laboratory discoveries to the clinic.

UR - http://www.scopus.com/inward/record.url?scp=61349128532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61349128532&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-08-0435

DO - 10.1158/1541-7786.MCR-08-0435

M3 - Article

VL - 7

SP - 157

EP - 167

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 2

ER -